Đang chuẩn bị liên kết để tải về tài liệu:
Anti-PD-1 antibody decreases tumourinfiltrating regulatory T cells

There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the difference of effect and its mechanism are unclear. | Anti-PD-1 antibody decreases tumourinfiltrating regulatory T cells